Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency

被引:0
|
作者
Arne Nagels
André Kirner-Veselinovic
Richard Wiese
Frieder M. Paulus
Tilo Kircher
Sören Krach
机构
[1] Philipps-University Marburg,Department of Psychiatry and Psychotherapy
[2] RWTH Aachen University,Department of Psychiatry and Psychotherapy
[3] Philipps-University Marburg,Institute for German Linguistics
[4] Philipps-University Marburg,Department of Neurology
关键词
-methyl-; -aspartate receptor; Ketamine; fMRI; Speech production; Schizophrenia; Glutamate;
D O I
暂无
中图分类号
学科分类号
摘要
The N-methyl-d-aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. Administered to healthy individuals, a subanesthetic dose of the noncompetitive NMDAR antagonist ketamine reproduces several psychopathological symptoms commonly observed in patients with schizophrenia. In a counterbalanced, placebo-controlled, double-blind, within-participants study, fifteen healthy subjects were administered a continuous subanesthetic S-ketamine infusion while cortical activation was measured using functional magnetic resonance imaging. While being scanned, subjects performed an overt word generation task. Ketamine-induced psychopathological symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). Ketamine administration elicited effects on psychopathology, including difficulties in abstract thinking, lack of spontaneity and flow of conversation as well as formal thought disorder. On a behavioral level, verbal fluency performance was unaffected. The PANSS score for formal thought disorder positively correlated with activation measures encompassing the left superior temporal gyrus, the right middle and inferior frontal gyrus and the precuneus. Difficulty in abstract thinking was correlated with pronounced activations in prefrontal as well as in anterior cingulate regions, whereas hyperactivations in the left superior temporal gyrus were found in association with a lack of spontaneity and flow of conversation. In the absence of behavioral impairments during verbal fluency, NMDAR blocking evoked psychopathological symptoms and cortical activations in regions previously reported in schizophrenia patients. The results provide further support for the hypothesis of an NMDAR dysfunction in the pathophysiology of schizophrenia.
引用
收藏
页码:403 / 414
页数:11
相关论文
共 50 条
  • [11] EFFECTS OF CLOZAPINE ON KETAMINE-INDUCED LINGUOPHARYNGEAL EVENTS IN RATS
    MARCO, LA
    JOSHI, RS
    BRIGHAM, TE
    ALDES, LD
    CHRONISTER, RB
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (01) : 171 - 173
  • [12] In search for ketamine-induced antidepressant-like effects
    Popik, Piotr
    AMINO ACIDS, 2009, 37 (01) : 29 - 29
  • [13] Effects of age and sex on ketamine-induced hyperactivity in rats
    Wilson, Chnistopher
    Kercher, Melanie
    Quinn, Belsida
    Murphy, Alexandra
    Fiegel, Carey
    McLaurin, Angel
    PHYSIOLOGY & BEHAVIOR, 2007, 91 (2-3) : 202 - 207
  • [14] Antipsychotic effects on ketamine-induced brain metabolic activation
    Duncan, GE
    Leipzig, JN
    Miyamoto, S
    Mailman, RB
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 56S - 57S
  • [15] EFFECTS OF CADMIUM AND VERAPAMIL ON KETAMINE-INDUCED ANESTHESIA IN MICE
    SHEN, Y
    SANGIAH, S
    VETERINARY AND HUMAN TOXICOLOGY, 1995, 37 (03) : 201 - 203
  • [16] Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man
    Sargo Aalto
    Jouni Ihalainen
    Jussi Hirvonen
    Jaana Kajander
    Harry Scheinin
    Heikki Tanila
    Kjell Någren
    Harry Vilkman
    Lars L. Gustafsson
    Erkka Syvälahti
    Jarmo Hietala
    Psychopharmacology, 2005, 182 : 375 - 383
  • [17] Ketamine-induced Changes in Neural Noise and their Relationship to Psychosis-like Symptoms
    Cortes-Briones, Jose
    Skosnik, Patrick
    D'Souza, Deepak
    Abdallah, Chadi
    Petrakis, Ismene
    Krystal, John
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S28 - S28
  • [18] Effects of cannabidiol on (s)-ketamine-induced psychopathology in healthy volunteers
    Bosi, DC
    Hallak, JEC
    Dursun, SM
    Deakin, JFW
    Zuardi, AW
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A80 - A80
  • [19] Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man
    Aalto, S
    Ihalainen, J
    Hirvonen, J
    Kajander, J
    Scheinin, H
    Tanila, H
    Någren, K
    Vilkman, H
    Gustafsson, LL
    Syvälahti, E
    Hietala, J
    PSYCHOPHARMACOLOGY, 2005, 182 (03) : 375 - 383
  • [20] Protective effects of stigmasterol against ketamine-induced psychotic symptoms: Possible behavioral, biochemical and histopathological changes in mice
    Monu Yadav
    Milind Parle
    Deepak Kumar Jindal
    Sameer Dhingra
    Pharmacological Reports, 2018, 70 : 591 - 599